메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Ting Deng (Sun Yat-sen University Cancer Center) Kaijiang Liu (Renji Hospital Shanghai Jiao Tong University School of Medicine Shanghai China) Liang Chen (Shandong Cancer Hospital and Institute Jinan China) Xiao-jun Chen (Department of Gynecology Obstetrics and Gynecology Hospital Fudan University Shanghai China) Hua Wen Li (Zhuhai People’s Hospital Zhuhai Hospital Affiliated with Jinan University Zhuhai China) Hongyan Guo (Peking University Third Hospital Beijing China) Huijiao Zhang (Zhangzhou Zhengxing Hospital Zhangzhou China) Libing Xiang (Zhongshan Hospital Fudan University) Xin Feng (Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou China) Xiaoyu Wang (The First Affiliated Hospital of Jinan University Guangzhou China) Hextan Y. S. Ngan (University of Hong Kong) Jianguo Zhao (Tianjin Central Hospital of Obstetrics and Gynecology Tianjin China) Dongling Zou (Chongqing University Cancer Hospital Chongqing China) Qing Liu (Sun Yat-sen University Cancer Center Guangzhou China) Jihong Liu (Sun Yat-sen University Cancer Center)
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.34 No.3
발행연도
2023.5
수록면
1 - 7 (7page)
DOI
10.3802/jgo.2023.34.e52

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: The Lymphadenectomy in Ovarian Neoplasms (LION) study revealed thatsystemic lymphadenectomy did not bring sur vival benefit for advanced ovarian cancerpatients with clinically normal lymph nodes and was associated with a higher incidence ofoperative complications. However, there is no consensus on whether lymphadenectomy hassur vival benefit or not in early epithelial ovarian cancer (EOC). Methods: We designed the LOVE study, a multicenter, randomized controlled, phase IIItrial to compare the efficacy and safety of comprehensive staging surger y with or withoutlymphadenectomy in stages IA-IIB EOC and fallopian tube carcinomas (FTC). The hypothesisis that the oncological outcomes provided by comprehensive staging surger y withoutlymphadenectomy are non-inferior to those of conventional completion staging surger yin early-stage EOC and FTC patients who have indications for post-operative adjuvantchemotherapy. Patients assigned to experimental group will undergo comprehensivestaging surger y, but lymphadenectomy. Patients assigned to comparative group will undergocompletion staging surger y including systematic pelvic and para-aortic lymphadenectomy. All subjects will receive 3–6 cycles of standard adjuvant chemotherapy. Major inclusioncriteria are pathologic confirmed stage IA-IIB EOC or FTC, and patients have indications foradjuvant chemotherapy either confirmed by intraoperative fast frozen section or previouspathology after an incomplete staging surger y. Major exclusion criteria are non-epithelial tumors and low-grade serous carcinoma. Patients with severe rectum involvement whichlead to partial rectum resection will be excluded. The sample size is 656 subjects. Primar yendpoint is disease-free sur vival.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0